Efficacy and Safety of Fluvoxamine in Body Dysmorphic Disorder
The DOI matches its Crossref record.
Abstract
BACKGROUND: Body dysmorphic disorder (BDD), a preoccupation with an imagined or slight defect in appearance, has been noted in case reports, retrospective studies, and clinical series to respond to serotonin reuptake inhibitors (SRIs). These data further suggest that the delusional variant of BDD (delusional disorder, somatic type) may also respond to SRIs. However, systematic pharmacologic treatment studies of BDD and its delusional variant are needed. METHOD: Thirty subjects with BDD or its delusional variant (DSM-IV) were prospectively treated in an open-label fashion with fluvoxamine for 16 weeks. Subjects were assessed at regular intervals with the Yale-Brown Obsessive Compulsive Scale Modified for BDD (BDD-YBOCS), the Clinical Global Impressions (CGI) scale, the Hamilton Rating Scale for Depression, the Brown Assessment of Beliefs Scale, and other measures. RESULTS: BDD-YBOCS scores (mean +/- SD) decreased from 31.1 +/- 5.4 at baseline to 16.9 +/- 11.8 at termination (p < .001). Nineteen (63.3%) subjects were rated as responders on the BDD-YBOCS and the CGI (10 [33.3%] were much improved, and 9 [30.0%] were very much improved). Delusional subjects were as likely to respond to fluvoxamine as nondelusional subjects, and delusionality significantly improved. All 5 responders who were delusional at baseline were no longer delusional at study endpoint. The mean dose of fluvoxamine was 238.3 +/- 85.8 mg/day, and mean time to response was 6.1 +/- 3.7 weeks. Fluvoxamine was generally well tolerated. CONCLUSION: These results suggest that fluvoxamine is a safe and effective treatment for BDD, including its delusional disorder variant. Controlled treatment trials are needed to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Axis I comorbidity in body dysmorphic disorder
Gunstad, J., & Phillips, K. A. (2003) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(03)00088-9 · Cited by 407
Self-citationSurgical and Nonpsychiatric Medical Treatment of Patients With Body Dysmorphic Disorder
Phillips, K. A., Grant, J., Siniscalchi, J., & Albertini, R. S. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.6.504 · Cited by 368
Self-citationPathophysiology of obsessive–compulsive disorder
Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Bioulac, B., Tignol, J., & Burbaud, P. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.004 · Cited by 341
A Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder
Phillips, K. A., Albertini, R. S., & Rasmussen, S. A. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.381 · Cited by 321
Self-citationOlivardia, R. (2001) · Harvard Review of Psychiatry · doi:10.1080/10673220127900 · Cited by 278
Hollander, E., Allen, A., Kwon, J., Aronowitz, B., Schmeidler, J., Wong, C., & Simeon, D. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1033 · Cited by 275
Rate of body dysmorphic disorder in dermatology patients
Phillips, K. A., Dufresne, R. G., Wilkel, C. S., & Vittorio, C. C. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90215-9 · Cited by 274
Self-citationBody Dysmorphic Disorder and Cosmetic Surgery
Crerand, C. E., Franklin, M. E., & Sarwer, D. B. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000242500.28431.24 · Cited by 265
Insight in obsessive compulsive disorder and body dysmorphic disorder
Eisen, J. L., Phillips, K. A., Coles, M. E., & Rasmussen, S. A. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2003.09.010 · Cited by 254
Self-citationAge at onset and clinical correlates in body dysmorphic disorder
Bjornsson, A. S., Didie, E. R., Grant, J. E., Menard, W., Stalker, E., & Phillips, K. A. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.03.019 · Cited by 245
Self-citationPhillips, K. A., & Hollander, E. (2008) · Body Image · doi:10.1016/j.bodyim.2007.12.003 · Cited by 214
Self-citationRecent advances in understanding and managing body dysmorphic disorder
Krebs, G., Fernández de la Cruz, L., & Mataix-Cols, D. (2017) · Evidence Based Mental Health · doi:10.1136/eb-2017-102702 · Cited by 84
Phillips, K. A., Keshaviah, A., Dougherty, D. D., Stout, R. L., Menard, W., & Wilhelm, S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091243 · Cited by 75
“In the other – a 16-week open-label fluvoxamine study – six responders who were subsequently treated in a clinical practice discontinued fluvoxamine; all six patients relapsed within four days to about two months (11).”
BackgroundSelf-citationFang, A., Matheny, N. L., & Wilhelm, S. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.003 · Cited by 44
New perspectives in the treatment of body dysmorphic disorder
Hong, K., Nezgovorova, V., & Hollander, E. (2018) · F1000Research · doi:10.12688/f1000research.13700.1 · Cited by 31
Metadata
- Authors
- Phillips, K. A., Dwight, M. M., & McElroy, S. L.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1998-04-15
- Volume
- 59
- Issue
- 4
- Pages
- 165-171
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2086984149
- Cited by
- 182
- References
- 0
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.